摘要
目的 对我院静脉用药调配中心审核干预的处方进行统计分析,为儿科合理使用静脉药品提供参考依据.方法 调取静脉配置中心2022 年4 月至2023 年4 月189637 份儿童静脉输液处方进行审核,对有干预或反馈记录的不合理用药处方进行分析.结果 汇总发现儿童静脉输液不合理处方810 份,约占所有静脉输液处方的0.427%.不合理处方类型主要包括用法用量不适宜、溶媒选用不适宜、药物配制浓度不适宜、药物配伍禁忌和超说明书用药,构成比分别为 36.5%、23.8%、18.0%、12.1%和 6.5%;各临床科室不合理处方排名前三名分别是PICU、CICU及血液肿瘤科,占比依次为24.1%、18.0%和16.8%.结论 目前我院儿童静脉输液仍存在不合理处方,审方药师应及时发现并进行干预,确保儿童静脉输液安全、合理.
Abstract
OBJECTIVE To anlalyze the irrational prescriptions of intravenous infusion for children,and to pro-vide a reference basis for the rational use of intravenous drugs by pediatrics.METHODS 189637 pediatric intrave-nous infusion prescriptions prescribed from April 2022 to April 2023 were reviewed,and the irrational prescriptions with intervention or feedback records were analyzed.RESULTS A total of 810 unreasonable prescriptions for intra-venous infusion in children were found,accounting for about 0.427%of all intravenous infusion prescriptions.The types of unreasonable prescriptions mainly included inappropriate dosage,inappropriate solvent,inappropriate concen-tration of drug,contraindications to drug compatibility and off-label use,with composition ratios of 36.5%,23.8%,18.0%,12.1%and 6.5%,respectively.From the incidence rate of unreasonable prescription in clinical depart-ment,the top three clinical department were PICU,CICU and hemato-oncology department,accounting for 24.1%,18.0%and 16.8%,respectively.CONCLUSION At present,there are still unreasonable prescription for intrave-nous infusion of children in our hospital,and the pharmacist should detect and intervene in time to ensure the safety and reasonableness of intravenous infusion for children.
维普
万方数据